Tags

Type your tag names separated by a space and hit enter

Tobacco Product Use Among Adults - United States, 2015.
MMWR Morb Mortal Wkly Rep. 2017 Nov 10; 66(44):1209-1215.MM

Abstract

Tobacco use remains the leading cause of preventable disease and death in the United States (1). Despite declining cigarette smoking prevalence among U.S. adults, shifts in the tobacco product landscape have occurred in recent years (2,3). Previous estimates of tobacco product use among U.S. adults were obtained from the National Adult Tobacco Survey, which ended after the 2013-2014 cycle. This year, CDC and the Food and Drug Administration (FDA) assessed the most recent national estimates of tobacco product use among adults aged ≥18 years using, for the first time, data from the 2015 National Health Interview Survey (NHIS), an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population. The 2015 NHIS adult core questionnaire included 33,672 adults aged ≥18 years, reflecting a 55.2% response rate. Data were weighted to adjust for differences in selection probability and nonresponse, and to provide nationally representative estimates. In 2015, 20.1 % of U.S. adults currently (every day or some days) used any tobacco product, 17.6% used any combustible tobacco product, and 3.9% used ≥2 tobacco products. By product, 15.1% of adults used cigarettes; 3.5% used electronic cigarettes (e-cigarettes); 3.4% used cigars, cigarillos, or filtered little cigars; 2.3% used smokeless tobacco; and 1.2% used regular pipes, water pipes, or hookahs.* Current use of any tobacco product was higher among males; persons aged <65 years; non-Hispanic American Indian/Alaska natives (AI/AN), whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a General Educational Development (GED) certificate; persons with annual household income of <$35,000; persons who were single, never married, or not living with a partner or divorced, separated, or widowed; persons who were insured through Medicaid or uninsured; persons with a disability; and persons who identified as lesbian, gay, or bisexual (LGB). Current use of any tobacco product was 47.2% among adults with serious psychological distress compared with 19.2% among those without serious psychological distress. Proven population-level interventions that focus on the diversity of tobacco product use are important to reducing tobacco-related disease and death in the United States (1).

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29121001

Citation

Phillips, Elyse, et al. "Tobacco Product Use Among Adults - United States, 2015." MMWR. Morbidity and Mortality Weekly Report, vol. 66, no. 44, 2017, pp. 1209-1215.
Phillips E, Wang TW, Husten CG, et al. Tobacco Product Use Among Adults - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(44):1209-1215.
Phillips, E., Wang, T. W., Husten, C. G., Corey, C. G., Apelberg, B. J., Jamal, A., Homa, D. M., & King, B. A. (2017). Tobacco Product Use Among Adults - United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 66(44), 1209-1215. https://doi.org/10.15585/mmwr.mm6644a2
Phillips E, et al. Tobacco Product Use Among Adults - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1209-1215. PubMed PMID: 29121001.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tobacco Product Use Among Adults - United States, 2015. AU - Phillips,Elyse, AU - Wang,Teresa W, AU - Husten,Corinne G, AU - Corey,Catherine G, AU - Apelberg,Benjamin J, AU - Jamal,Ahmed, AU - Homa,David M, AU - King,Brian A, Y1 - 2017/11/10/ PY - 2017/11/10/entrez PY - 2017/11/10/pubmed PY - 2017/11/29/medline SP - 1209 EP - 1215 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 66 IS - 44 N2 - Tobacco use remains the leading cause of preventable disease and death in the United States (1). Despite declining cigarette smoking prevalence among U.S. adults, shifts in the tobacco product landscape have occurred in recent years (2,3). Previous estimates of tobacco product use among U.S. adults were obtained from the National Adult Tobacco Survey, which ended after the 2013-2014 cycle. This year, CDC and the Food and Drug Administration (FDA) assessed the most recent national estimates of tobacco product use among adults aged ≥18 years using, for the first time, data from the 2015 National Health Interview Survey (NHIS), an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population. The 2015 NHIS adult core questionnaire included 33,672 adults aged ≥18 years, reflecting a 55.2% response rate. Data were weighted to adjust for differences in selection probability and nonresponse, and to provide nationally representative estimates. In 2015, 20.1 % of U.S. adults currently (every day or some days) used any tobacco product, 17.6% used any combustible tobacco product, and 3.9% used ≥2 tobacco products. By product, 15.1% of adults used cigarettes; 3.5% used electronic cigarettes (e-cigarettes); 3.4% used cigars, cigarillos, or filtered little cigars; 2.3% used smokeless tobacco; and 1.2% used regular pipes, water pipes, or hookahs.* Current use of any tobacco product was higher among males; persons aged <65 years; non-Hispanic American Indian/Alaska natives (AI/AN), whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a General Educational Development (GED) certificate; persons with annual household income of <$35,000; persons who were single, never married, or not living with a partner or divorced, separated, or widowed; persons who were insured through Medicaid or uninsured; persons with a disability; and persons who identified as lesbian, gay, or bisexual (LGB). Current use of any tobacco product was 47.2% among adults with serious psychological distress compared with 19.2% among those without serious psychological distress. Proven population-level interventions that focus on the diversity of tobacco product use are important to reducing tobacco-related disease and death in the United States (1). SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/29121001/Tobacco_Product_Use_Among_Adults___United_States_2015_ L2 - https://doi.org/10.15585/mmwr.mm6644a2 DB - PRIME DP - Unbound Medicine ER -